Skip to main content
PMC home page
Philosophical Transactions of the Royal Society B: Biological Sciences logoLink to Philosophical Transactions of the Royal Society B: Biological Sciences
. 1997 Dec 29;352(1363):1829–1835. doi: 10.1098/rstb.1997.0168

Epidemiological aspects of ageing.

K T Khaw 1
PMCID: PMC1692126  PMID: 9460067

Abstract

A major societal challenge is to improve quality of life and prevent or reduce disability and dependency in an ageing population. Increasing age is associated with increasing risk of disability and loss of independence, due to functional impairments such as loss of mobility, hearing and vision; a major issue must be how far disability can be prevented. Ageing is associated with loss of bone tissue, reduction in muscle mass, reduced respiratory function, decline in cognitive function, rise in blood pressure and macular degeneration which predispose to disabling conditions such as osteoporosis, heart disease, dementia and blindness. However, there are considerable variations in different communities in terms of the rate of age-related decline. Large geographic and secular variations in the age-adjusted incidence of major chronic diseases such as stroke, hip fracture, coronary heart disease, cancer, visual loss from cataract, glaucoma and macular degeneration suggest strong environmental determinants in diet, physical activity and smoking habit. The evidence suggests that a substantial proportion of chronic disabling conditions associated with ageing are preventable, or at least postponable and not an inevitable accompaniment of growing old. Postponement or prevention of these conditions may not only increase longevity, but, more importantly, reduce the period of illnesses such that the majority of older persons may live high-quality lives, free of disability, until very shortly before death. We need to understand better the factors influencing the onset of age-related disability in the population, so that we have appropriate strategies to maintain optimal health in an ageing population.

Full Text

The Full Text of this article is available as a PDF (250.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barker D. J. Maternal and fetal origins of coronary heart disease. J R Coll Physicians Lond. 1994 Nov-Dec;28(6):544–551. [PMC free article] [PubMed] [Google Scholar]
  2. Busch H., von Cranach M., Gulbinat W., Renfordt E., Tegeler J. Reliability of the AMDP-system. A preliminary report on a multicentre exercise on the reliability of psychopathological assessment. Acta Psychiatr Scand. 1980 Oct;62(4):382–392. doi: 10.1111/j.1600-0447.1980.tb00624.x. [DOI] [PubMed] [Google Scholar]
  3. Chapuy M. C., Arlot M. E., Duboeuf F., Brun J., Crouzet B., Arnaud S., Delmas P. D., Meunier P. J. Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med. 1992 Dec 3;327(23):1637–1642. doi: 10.1056/NEJM199212033272305. [DOI] [PubMed] [Google Scholar]
  4. Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Prospective studies collaboration. Lancet. 1995 Dec 23;346(8991-8992):1647–1653. [PubMed] [Google Scholar]
  5. Clarke R., Frost C., Collins R., Appleby P., Peto R. Dietary lipids and blood cholesterol: quantitative meta-analysis of metabolic ward studies. BMJ. 1997 Jan 11;314(7074):112–117. doi: 10.1136/bmj.314.7074.112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Collins R., Peto R., MacMahon S., Hebert P., Fiebach N. H., Eberlein K. A., Godwin J., Qizilbash N., Taylor J. O., Hennekens C. H. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet. 1990 Apr 7;335(8693):827–838. doi: 10.1016/0140-6736(90)90944-z. [DOI] [PubMed] [Google Scholar]
  7. Cummings S. R., Black D. Bone mass measurements and risk of fracture in Caucasian women: a review of findings from prospective studies. Am J Med. 1995 Feb 27;98(2A):24S–28S. doi: 10.1016/s0002-9343(05)80041-5. [DOI] [PubMed] [Google Scholar]
  8. Curfman G. D. The health benefits of exercise. A critical reappraisal. N Engl J Med. 1993 Feb 25;328(8):574–576. doi: 10.1056/NEJM199302253280810. [DOI] [PubMed] [Google Scholar]
  9. Doll R., Peto R., Wheatley K., Gray R., Sutherland I. Mortality in relation to smoking: 40 years' observations on male British doctors. BMJ. 1994 Oct 8;309(6959):901–911. doi: 10.1136/bmj.309.6959.901. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Dubbelman R., Jonxis J. H., Muskiet F. A., Saleh A. E. Age-dependent vitamin D status and vertebral condition of white women living in Curaçao (The Netherlands Antilles) as compared with their counterparts in The Netherlands. Am J Clin Nutr. 1993 Jul;58(1):106–109. doi: 10.1093/ajcn/58.1.106. [DOI] [PubMed] [Google Scholar]
  11. Fries J. F. Physical activity, the compression of morbidity, and the health of the elderly. J R Soc Med. 1996 Feb;89(2):64–68. doi: 10.1177/014107689608900202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kannel W. B., Doyle J. T., Shephard R. J., Stamler J., Vokonas P. S. Prevention of cardiovascular disease in the elderly. J Am Coll Cardiol. 1987 Aug;10(2 Suppl A):25A–28A. doi: 10.1016/s0735-1097(87)80443-6. [DOI] [PubMed] [Google Scholar]
  13. Law M. R., Frost C. D., Wald N. J. By how much does dietary salt reduction lower blood pressure? I--Analysis of observational data among populations. BMJ. 1991 Apr 6;302(6780):811–815. doi: 10.1136/bmj.302.6780.811. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Law M. R., Frost C. D., Wald N. J. By how much does dietary salt reduction lower blood pressure? III--Analysis of data from trials of salt reduction. BMJ. 1991 Apr 6;302(6780):819–824. doi: 10.1136/bmj.302.6780.819. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Manton K. G. Changing concepts of morbidity and mortality in the elderly population. Milbank Mem Fund Q Health Soc. 1982 Spring;60(2):183–244. [PubMed] [Google Scholar]
  16. Murray C. J., Lopez A. D. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet. 1997 May 24;349(9064):1498–1504. doi: 10.1016/S0140-6736(96)07492-2. [DOI] [PubMed] [Google Scholar]
  17. Murray C. J., Lopez A. D. Regional patterns of disability-free life expectancy and disability-adjusted life expectancy: global Burden of Disease Study. Lancet. 1997 May 10;349(9062):1347–1352. doi: 10.1016/S0140-6736(96)07494-6. [DOI] [PubMed] [Google Scholar]
  18. Neaton J. D., Wentworth D. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Multiple Risk Factor Intervention Trial Research Group. Arch Intern Med. 1992 Jan;152(1):56–64. [PubMed] [Google Scholar]
  19. Poulter N. R., Khaw K. T., Hopwood B. E., Mugambi M., Peart W. S., Rose G., Sever P. S. The Kenyan Luo migration study: observations on the initiation of a rise in blood pressure. BMJ. 1990 Apr 14;300(6730):967–972. doi: 10.1136/bmj.300.6730.967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Worth R. M., Kato H., Rhoads G. G., Kagan K., Syme S. L. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: mortality. Am J Epidemiol. 1975 Dec;102(6):481–490. doi: 10.1093/oxfordjournals.aje.a112186. [DOI] [PubMed] [Google Scholar]
  21. de Lorgeril M., Renaud S., Mamelle N., Salen P., Martin J. L., Monjaud I., Guidollet J., Touboul P., Delaye J. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet. 1994 Jun 11;343(8911):1454–1459. doi: 10.1016/s0140-6736(94)92580-1. [DOI] [PubMed] [Google Scholar]

Articles from Philosophical Transactions of the Royal Society B: Biological Sciences are provided here courtesy of The Royal Society

RESOURCES